Vimarsana
Biggest News Aggregation in the World

Page 2 - Obi Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Obi Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Obi Pharma Today - Breaking & Trending Today

OBI Pharma Enters License Agreement with Odeon Therapeutics for the Rights of OBI-999 and OBI-833 in China, Hong Kong and Macau - Vimarsana News

OBI Pharma Enters License Agreement with Odeon Therapeutics for the Rights of OBI-999 and OBI-833 in China, Hong Kong and Macau

/PRNewswire/ -- OBI Pharma, Inc. (OBI), a Taiwan biopharma company (TPEx: 4174), and Odeon Therapeutics (Odeon), a China biopharma company, have entered into...

OBI Pharma Enters License Agreement with Odeon Therapeutics for the Rights of OBI-999 and OBI-833 in China, Hong Kong and Macau - Vimarsana News

OBI Pharma Enters License Agreement with Odeon Therapeutics for the Rights of OBI-999 and OBI-833 in China, Hong Kong and Macau

/PRNewswire/ -- OBI Pharma, Inc. (OBI), a Taiwan biopharma company (TPEx: 4174), and Odeon Therapeutics (Odeon), a China biopharma company, have entered into...

OBI Pharma Announces Phase 2 Studies Patient Enrollment for OBI-999 and OBI-3424 - Vimarsana News

OBI Pharma Announces Phase 2 Studies Patient Enrollment for OBI-999 and OBI-3424

/PRNewswire/ -- OBI Pharma, a Taiwan biopharma company (TPEx: 4174), today announced that the first patients have been enrolled in both of the Phase 2 studies...

Taiwan rejects Covid-19 vaccine from UBI Pharma in blow to self-sufficiency goal - Vimarsana News

Taiwan rejects Covid-19 vaccine from UBI Pharma in blow to self-sufficiency goal

Second home-grown candidate does not trigger enough antibodies, according to regulator.

Source: scmp.com
Related Topics:
Phase Iii TrialsObi Pharma